However, it remains to be established whether loss of the tumor suppressor PML contributes to changes in the host immune response or the tumor microenvironment, perhaps resulting in either immunosurveillance or immune escape, by modulation of transcription factors. The gene discussed is PML; the disease is neoplasm.